NCT06583811View on ClinicalTrials.gov

Remifentanil and Remimazolam to Limit Patient Movement

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 10, 2025

Conditions
Long-Eye Surgeries
Interventions
DRUG

Remifentanil

to compare remifentanil and remimazolam to limit patient movement during long-eye surgeries under local anesthesia.

Trial Locations (1)

Unknown

RECRUITING

Al-Azhar University hospitals, Cairo

All Listed Sponsors
collaborator

Al-Azhar University

OTHER

lead

Egymedicalpedia

INDUSTRY